From: Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study
Markers
Group
P-value
IDC
DCIS
n (%)
β1
Negative
151 (67,1)
45 (67,2)
1.000a
Positive
74 (32,9)
22 (32,8)
PR
87 (38,7)
20 (29,9)
0.198a
138 (61,3)
47 (70,1)
ER
76 (33,8)
17 (25,4)
0.233a
149 (66,2)
50 (74,6)